P. Rosenthal

Antimalarial Chemotherapy: Mechanisms of Action, Resistance, and New Directions in Drug Discovery - Infectious Disease P. Rosenthal 2001 edition

Marc Notes: Includes bibliographical references and index. Review Quotes: "With contributions from 41 different authors, this book provides a welcome collection of short reviews covering numerous topics in antimalarial chemotherapy. ...this book will offer a useful review for those who study malaria and, more importantly, an entry point into antimalarial chemotherapy for those new in the field." - Journal of Medicinal Chemistry ."..the publication of a new on antimalarial chemotheraphy is very topcial and timely. Philip Rosenthal has put together a very comprehensive book on the current status of research in this important field of medicianl chemistry.... The part on established antimalarial drugs covers all drugs currently in clinical application and trials.... Special emphasis is put in many articles on aspects of toxicity, therapy, problems, and future developments....the editor has managed to compile the contributions in such a way that a comprehensive picture of the current status emerges and the book feels more like a single-author publication than an edited work.... The book is a must for chemists, biologists, and health professionals involved in malaria research." - ChemBioChem ."..thought provoking with its new leads to drug discovery...an essential addition to the libraries and an essential reading book for malariologists." -The National Journal of IndiaJacket Description/Back: At a time when the control of malaria is increasingly limited by the growing resistance of malaria parasites to available drugs, the need for a much better use of the existing drugs, as well as for the development of new antimalarials, has become urgent. In Antimalarial Chemotherapy: Mechanisms of Action, Resistance, and New Directions in Drug Discovery, a panel of leading malaria experts drawn from academia, the military, and international health organizations survey the latest scientific understanding of antimalarial chemotherapy, emphasizing the molecular mechanisms of resistance and the description of important new targets. The survey covers the current status of malarial and antimalarial chemotherapy, the relevant biology and biochemistry of malaria parasites, the antimalarial drugs currently available, and new chemical approaches to and possible new targets for chemotherapy. It also discusses, as essential background, the history of chemotherapy, the practical aspects of therapy, and the public health consequences of current problems in antimalarial chemotherapy. Comprehensive and cutting-edge, Antimalarial Chemotherapy: Mechanisms of Action, Resistance, and New Directions in Drug Discovery clearly delineates all the basic and clinical research now addressing one of the world's major unresolved disease problems, work that is now powerfully driving the rapid pace of antimalarial drug discovery today. Table of Contents: I. Introduction The Need for New Approaches to Antimalarial Chemotherapy Philip J. Rosenthal and Louis H. Miller The History of Antimalarial Drugs Steven R. Meshnick and Mary J. Dobson Transport and Trafficking in Plasmodium-Infected Red Cells Kasturi Haldar and Thomas Akompong The Plasmodium Food Vacuole Ritu Banerjee and Daniel E. Goldberg Clinical and Public Health Implications of Antimalarial Drug Resistance Piero L. Olliaro and Peter B. Bloland II. Established Antimalarial Drugs and Compounds Under Clinical Development Chloroquine and Other Quinoline Antimalarials Leann Tilley, Paul Loria, and Mick Foley 8-Aminoquinolines Ralf P. Brueckner, Colin Ohrt, J. Kevin Baird, and Wilbur K. Milhous Mechanisms of Quinoline Resistance Grant Dorsey, David A. Fidock, Thomas E. Wellems, and Philip J. Rosenthal Folate Antagonists and Mechanisms of Resistance Christopher V. Plowe Artemisinin and Its Derivatives Steven R. Meshnick. Atovaquone-Proguanil Combination, Akhil B. Vaidya The Antimalarial Drug Portfolio and Research Pipeline Piero L. Olliaro and Wilbur K. Milhous III. New Compounds, New Approaches, and New Targets Novel Quinoline Antimalarials Paul A. Stocks, Kaylene J. Raynes, and Stephen A. Ward New Antimalarial Trioxanes and Endoperoxides Gary H. Posner, Mikhail Krasavin, Michael McCutchen, Poonsakdi Ploypradith, John P. Maxwell, Jeffrey S. Elias, and Michael H. Parker Antibiotics and the Plasmodial Plastid Organelle Barbara Clough and R. J. M. (Iain) Wilson Fresh Paradigms for Curative Antimetabolites Pradipsinh K. Rathod. Iron Chelators, Mark Loyevsky and Victor R. Gordeuk Protease Inhibitors Philip J. Rosenthal Inhibitors of Phospholipid Metabolism Henri Joseph Vial and Michele Calas Development of New Malaria Chemotherapy by Utilization of Parasite-Induced Transport Annette M. Gero and Alexander L. Weis"Publisher Marketing: Malaria is one of the most important disease problems in the world and its control is increasingly limited by resistance of the disease to available drugs. New strategies and drugs are urgently needed for treating malaria. While challenges for the effective treatment and control of malaria are great, our current opportunities have lead to a more rational approach to antimalarial chemotherapy, where we are using existing agents and developing new drugs designed to target specific parasite pathways. This book presents an understanding of the mechanisms of action and resistance of existing agents which will enable the development of new strategies to use these or related compounds in a fashion that will reduce the occurrence of drug resistance. It also presents information on new compounds including agents that are related to existing effective antimalarials and some new targets. By understanding the material presented here, physicians and researchers will be able to take a safer and more effective approach to the treatment and prevention of malaria. Review Citations:

Scitech Book News 06/01/2001 pg. 93 (EAN 9780896036703, Hardcover)